p53 Gene Identified as Key Target in Ulcerative Colitis Treatment: Study from Berlin Offers New Hope
Research from Max Delbrück Center and Charité - Universitätsmedizin Berlin suggests new therapeutic approaches to prevent disease progression to cancer